PCC0208017, a novel small-molecule inhibitor of MARK3/MARK4, suppresses glioma progression in vitro and in vivo

• Main Authors: Fangfang Li (Author), Zongliang Liu (Author), Heyuan Sun (Author), Chunmei Li (Author), Wenyan Wang (Author), Liang Ye (Author), Chunhong Yan (Author), Jingwei Tian (Author), Hongbo Wang (Author)
• Format: Book
• Published: Elsevier, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Gliomas are the most common primary intracranial neoplasms among all brain malignancies, and the microtubule affinity regulating kinases (MARKs) have become potential drug targets for glioma. Here, we report a novel dual small-molecule inhibitor of MARK3 and MARK4, designated as PCC0208017. In vitro...